HPV vaccine cuts precancer risk by over 50 per cent when given early, study finds
The study showed that women who received at least one dose of the quadrivalent HPV vaccine had a 37 per cent lower incidence of high-grade vulvovaginal lesions compared with unvaccinated women
By Sakshi Srivastava December 24, 2025
